SIGA Technologies, Inc. (SIGA)
| Market Cap | 207.66M -55.5% |
| Revenue (ttm) | 52.36M -69.6% |
| Net Income | 686,200 -99.1% |
| EPS | 0.01 -99.1% |
| Shares Out | 71.86M |
| PE Ratio | 302.05 |
| Forward PE | 178.64 |
| Dividend | $0.60 (20.76%) |
| Ex-Dividend Date | Apr 7, 2026 |
| Volume | 177,100 |
| Open | 3.130 |
| Previous Close | 3.140 |
| Day's Range | 2.885 - 3.130 |
| 52-Week Range | 2.830 - 7.105 |
| Beta | 1.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 9, 2026 |
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Financial Performance
In 2025, SIGA Technologies's revenue was $94.57 million, a decrease of -31.82% compared to the previous year's $138.72 million. Earnings were $23.28 million, a decrease of -60.69%.
Financial StatementsNews
Siga Technologies chief scientific officer Dennis Hruby retires
Siga Technologies (SIGA) announced that Dennis Hruby, executive VP and chief scientific officer, will retire effective immediately, concluding more than 30 years with the company.
SIGA Technologies Earnings Call Transcript: Q3 2026
Nine-month product revenue was $42M, with no Q3 product sales, and the quarter ended with $116M cash and no debt. A five-year Canadian contract adds up to $15M, while U.S. procurement timing remains uncertain and the PEP filing is delayed to 2028.
SIGA Technologies Earnings release: Q3 2026
SIGA Technologies released its Q3 2026 earnings on November 9, 2026, summarizing the period's financial results.
SIGA Technologies Quarterly report: Q3 2026
SIGA Technologies has published its Q3 2026 quarterly earnings report on November 9, 2026.
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEW...
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ: SIGA), a commercial stage pharmaceutical company, announced today that Dennis Hruby, Ph.D., Executive Vice President and Chief Sc...
SIGA Technologies Slides: Corporate presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on November 9, 2026.
SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference...
Siga Technologies awarded $15M oral Tpoxx contract from PSPC
Siga Technologies (SIGA) announced that Public Services and Procurement Canada, or PSPC, has awarded Siga a new contract for the procurement of oral Tpoxx, an antiviral medication used to treat…
SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®
Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces
SIGA Technologies Slides: Company presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on August 7, 2026.
SIGA Technologies Earnings Call Transcript: Q2 2026
Q2 2026 saw $38M in product revenues, driven by U.S. and international TPOXX deliveries, with net income of $12M and strong cash reserves. Progress continues on new U.S. contracts and international expansion, despite slower government procurement cycles.
SIGA Technologies Earnings release: Q2 2026
SIGA Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
SIGA Technologies Quarterly report: Q2 2026
SIGA Technologies has published its Q2 2026 quarterly earnings report on August 6, 2026.
SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference...
SIGA Technologies Transcript: AGM 2026
The meeting reviewed strong 2025 financials, highlighted strategic advances in TPOXX development, and approved all shareholder proposals, including board elections, auditor ratification, executive compensation, and a stock incentive plan amendment. Dividends and preparedness initiatives were emphasized.
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on May 8, 2026, providing details for shareholder voting and corporate governance matters.
SIGA Technologies Earnings Call Transcript: Q1 2026
Minimal Q1 deliveries led to a net loss, but a strong cash position enabled a special dividend. International expansion continues with a $13M Asia Pacific order and a new MENA partnership, while long-term outlook remains positive amid ongoing government engagement.
SIGA Technologies Earnings release: Q1 2026
SIGA Technologies released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
SIGA Technologies Quarterly report: Q1 2026
SIGA Technologies has published its Q1 2026 quarterly earnings report on May 7, 2026.
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 3...
SIGA Technologies Slides: Corporate presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on May 7, 2026.
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conferenc...
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.